
Director, Clinical Scientist
Posted 23 hours ago

Posted 23 hours ago
This is a fully remote position, open to applicants in United States.
β’ Assist the Medical Monitor or act as the clinical lead for designated Phase 1a/1b studies and upcoming late-stage programs.
β’ Participate in or supervise study initiation, site activation, enrollment, medical monitoring, data cleaning, data analysis, and clinical study report preparation.
β’ Write, review, and manage study protocols, protocol amendments, investigator brochures, informed consent forms, and clinical study reports.
β’ Collaborate with investigators and CROs to design and execute clinical studies.
β’ Offer scientific and medical insights into study design, endpoints, inclusion/exclusion criteria, dose escalation schemas, and stopping rules.
β’ Conduct investigator meetings, safety review committee gatherings, and site initiation visits.
β’ Act as the main medical contact for clinical site investigators and study teams.
β’ Contribute to clinical development plans, contingency plans, and overall program strategy.
β’ Provide technical and scientific guidance to achieve program milestones and manage budgets.
β’ Convert preclinical and non-clinical findings into clinical development hypotheses and opportunities.
β’ Integrate emerging clinical data to shape ongoing study strategies and reverse translation.
β’ Engage with clinical investigators, thought leaders, and cooperative groups.
β’ Represent BBOT at scientific conferences and investigator meetings.
β’ Ensure compliance of clinical trial activities with ICH-GCP, relevant regulatory guidelines, and BBOT SOPs.
β’ Assist in audit and inspection readiness.
β’ Collaborate across various functions, including Clinical Operations, Regulatory Affairs, Clinical Pharmacology, Translational Medicine, Biostatistics, and Safety for cohesive program execution.
β’ Ph.D. or Pharm.D. in a relevant scientific or clinical field, with a minimum of 3 years of oncology clinical development experience in the pharmaceutical or biotechnology industry.
β’ Other scientific or clinical degrees with at least 5-8 years of oncology clinical development experience in a pharmaceutical or biotechnology context, or an M.D. with clinical development experience will also be considered.
β’ Experience in all facets of protocol conduct in early-phase oncology, including protocol development, study initiation, execution, data analysis, and reporting.
β’ Ability to collaborate across various functions in a team-oriented environment, including Clinical Operations, Regulatory Affairs, Translational Medicine, and Clinical Pharmacology.
β’ Excellent written and verbal communication skills, with experience in drafting clinical documents (protocols, IBs, CSRs) and presenting data to both internal and external stakeholders.
β’ Strong analytical and critical thinking abilities; capable of interpreting and synthesizing complex clinical data and translating findings into clear, actionable recommendations.
β’ Proven track record of delivering results within tight timelines; adept at prioritizing tasks and maintaining high-performance standards and attention to detail.
β’ Deep dedication to enhancing patient lives and a passion for developing innovative therapeutics in oncology.
β’ Willingness to thrive in a fast-paced, high-accountability, small-company setting; demonstrating professionalism, interpersonal skills, intellectual curiosity, initiative, and the ability to challenge assumptions and identify new solutions to complex issues.
β’ Previous experience in a lean or startup biotech environment is highly preferred.
β’ Willingness to travel domestically and internationally to attend scientific conferences and clinical study sites as required.
β’ Adherence to ICH-GCP, applicable regulatory guidelines, and BBOT SOPs.
β’ Annual performance bonus.
β’ Company equity.
β’ Comprehensive health benefits.
Eli Lilly and Company
Crossroads
Pierre Fabre Group
Ceribell β Point-of-Care EEG
Get handpicked remote jobs straight to your inbox weekly.